NEW YORK (GenomeWeb) – Danaher today reported an 11 percent year-over-year increase in its fourth quarter revenues, with its Life Sciences and Diagnostics segments growing above the companywide rate.

Danaher also announced a transition plan for Daniel Comas, who will step down as CFO on Jan. 1, 2019, to be replaced by Matthew McGrew.

For the three months ended Dec. 31, 2017, total revenues came in at $5.09 billion, up from $4.58 billion in the year-ago period, and beating the consensus Wall Street estimate of $4.98 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.